Curlin Administration Sets recalled due to serious medical hazard
A recall is being issued by Moog Medical Devices Group, Salt Lake City, Utah, for some lots of Curlin Intravenous Administration Sets due to a potential device defect. Use of the affected sets may cause blood loss, an under-delivery of prescribed medication or fluid, or a potential delay in therapy. Continued use may cause serious injury or death. Customers and distributors will be notified how to obtain replacement administration sets. Patients in a home environment should contact their home healthcare provider or clinician for proper handling and replacement of an affected set. More information regarding this recall can be obtained by contacting Moog’s customer service department. The packaging for affected administration sets contain one of the following reference codes imprinted in the upper right hand corner: 340-4114, 340-4114, 340-4126, 340-4128, 340-4128-V, 340-4130, 340-4130-V, 340-4133, 340-4137, 340-4144, 340-4165, 340-4166, 340-4173, or 340-4176. The administrator set packaging for affected units also includes one of the following lot numbers imprinted in it lower right hand corner: CF1127990, CF1134390, CF1200492, CF1202592, CF1127991, CF1134391, CF1205492, CF1208091, CF1200493, CF1204092, CF1206890, CF120809, CF1127992, CF1133490, CF1206891, CF1200293, CF1129990, CF1134392, CF1200494, CF1204093, CF1203391, CF1205493, CF1130190, CF1134990, CF1200294, CF1204091, CF1206090, CF1130690, CF1134393, CF1134393, or CF1201893. This voluntary recall was issued at the request of the United States Food and Drug Administration after a routine product quality inspection revealed the presence of a reverse pump segment in some units allowing the possibility for reverse flow during routine use, a circumstance that could cause serious medical issues for the user.
